<SEC-DOCUMENT>0001140361-23-058152.txt : 20231218
<SEC-HEADER>0001140361-23-058152.hdr.sgml : 20231218
<ACCEPTANCE-DATETIME>20231218161125
ACCESSION NUMBER:		0001140361-23-058152
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231218
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231218
DATE AS OF CHANGE:		20231218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IONIS PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000874015
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				330336973
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19125
		FILM NUMBER:		231493835

	BUSINESS ADDRESS:	
		STREET 1:		2855 GAZELLE COURT
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92010
		BUSINESS PHONE:		7609319200

	MAIL ADDRESS:	
		STREET 1:		2855 GAZELLE COURT
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ISIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20016866_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:ions="http://ionispharma.com/20231218" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_637afafd24c845dda43b8d058a1c395c" contextRef="c20231218to20231218" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_10fa7a005dce489587912448509cfd59" contextRef="c20231218to20231218">0000874015</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ions-20231218.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20231218to20231218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000874015</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-18</xbrli:startDate><xbrli:endDate>2023-12-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C.&#160; 20549</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_23b73c8d977446e8b79798ca025c5831" contextRef="c20231218to20231218">8-K</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES EXCHANGE ACT OF 1934</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">
<div>Date of report (Date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_3cd79732e299404b8ec4908d412a98ed" contextRef="c20231218to20231218" format="ixt:date-monthname-day-year-en">December 18, 2023</ix:nonNumeric></div>

        <div><br />
        </div>

      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: center;">&#160;<span style="font-size: 24pt;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_e59de8cd1a8849acaca64b66459a21e0" contextRef="c20231218to20231218">IONIS PHARMACEUTICALS, INC.</ix:nonNumeric></span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact Name of Registrant as Specified in Charter)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_bb6244741abf444aac7d588413d5b20f" contextRef="c20231218to20231218" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(State or Other Jurisdiction of Incorporation)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_83e97852a88e4f4fbe696a96cb31bbf3" contextRef="c20231218to20231218">000-19125</ix:nonNumeric><br />
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_5a98d6769c444caeb03fbfbc6529abd2" contextRef="c20231218to20231218">33-0336973</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(Commission File No.)</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_638a5a277a0248bab88de621964c4eba" contextRef="c20231218to20231218">2855 Gazelle Court</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_025c224f7ec9473f950212789c5f7e70" contextRef="c20231218to20231218">Carlsbad</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_058b40592ef34728a498368f41bae1f4" contextRef="c20231218to20231218">CA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_f9ab4efc9be64341a96874e8d1f36b8a" contextRef="c20231218to20231218">92010</ix:nonNumeric></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Address of Principal Executive Offices and Zip Code)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_b708c5f80c3e40f680249eddfe0c91cf" contextRef="c20231218to20231218">760</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_5cec64638b4e47e9a22af06a234c10b8" contextRef="c20231218to20231218">931-9200</ix:nonNumeric></span></div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.7pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_dafa55dc224f44daad9dc3a09daa8219" contextRef="c20231218to20231218" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: -18.7pt; margin-left: 18.7pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.7pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_32b1206aa0f74514ad9952ed255e1951" contextRef="c20231218to20231218" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: -18.7pt; margin-left: 18.7pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.7pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_38244749a2c5401ca2a7d6a217c2b876" contextRef="c20231218to20231218" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: -18.7pt; margin-left: 18.7pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18.7pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_160fcfdf1d1e4760999c48b63c926873" contextRef="c20231218to20231218" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 31.1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Title of each class</div>
            </td>

    <td style="width: 4.7%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 17.22%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Trading symbol</div>
            </td>

    <td style="width: 4.57%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 42.41%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 31.1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_aff3de112578476f82d62bab7ade63bc" contextRef="c20231218to20231218">Common Stock, $.001 Par Value</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 4.7%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 17.22%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">&#8220;<ix:nonNumeric name="dei:TradingSymbol" id="Fact_1ea1212e10d34e84983765112731d383" contextRef="c20231218to20231218">IONS</ix:nonNumeric>&#8221;</div>
            </td>

    <td style="width: 4.57%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 42.41%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_70a6b61e823e4e8a8ba368f1fccb69d8" contextRef="c20231218to20231218" format="ixt-sec:exchnameen">The Nasdaq Stock Market, LLC</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or
        Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</div>

      <div style="text-align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Emerging growth company&#160;&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_6e6884befc9548299c4b8322b6a439c1" contextRef="c20231218to20231218" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: 'Times New Roman'; font-size: 10pt;">&#9744;</span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Entry into a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">On December 18, 2023, Ionis Pharmaceuticals, Inc. issued a press release announcing it has entered into a license agreement with Otsuka Pharmaceutical Co., Ltd. (&#8220;<span style="font-weight: bold; font-style: italic;">Otsuka</span>&#8221;) under which Otsuka obtains exclusive rights in Europe to commercialize donidalorsen, an investigational prophylactic treatment for hereditary angioedema (HAE).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">A copy of this press release is attached as Exhibit 99.1 to this Current Report and incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><span style="text-decoration: underline;">Exhibit No.</span></div>
            </td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;"><span style="text-decoration: underline;">Description</span></div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top; text-align: center;"><a href="ef20016866_ex99-1.htm">99.1</a></td>

    <td rowspan="1" style="width: 90%; vertical-align: top;">Press Release dated December 18, 2023.</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top; text-align: center;">&#160;</td>

    <td rowspan="1" style="width: 90%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top; text-align: center;">104</td>

    <td rowspan="1" style="width: 90%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-variant: small-caps; font-weight: bold;">SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
        behalf by the undersigned, thereunto duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; font-variant: small-caps; font-weight: bold;">Ionis Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Dated:&#160; December 18, 2023</div>
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">By:</div>
            </td>

    <td style="width: 47%; vertical-align: top; border-bottom: 2px solid black; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">/s/ Patrick R. O&#8217;Neil</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; font-variant: small-caps; font-weight: bold;">Patrick R. O&#8217;Neil</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Executive Vice President, Chief Legal Officer and General Counsel</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20016866_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--><font style="font-size: 10pt;">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 99.1</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;<img height="68" width="211" src="image0.jpg"></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis announces European licensing agreement with Otsuka for donidalorsen in hereditary angioedema</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="za54e8c1269a34102ba923b9b5184a949" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8211;</td>
              <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="font-family: 'Times New Roman'; font-style: italic;">Otsuka to leverage strong commercial infrastructure and rare disease experience to reach European HAE patients</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="zbf341c74df2a48fbaadd4e95606a8c3c" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8211;</td>
              <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="font-family: 'Times New Roman'; font-style: italic;">Ionis plans to independently bring donidalorsen to U.S. patients if approved</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="za14bd50637f54fff9afedf296c465434" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8211;</td>
              <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="font-family: 'Times New Roman'; font-style: italic;">Donidalorsen Phase 3 results expected in the first half of 2024</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">
        <div><br>
        </div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">CARLSBAD, Calif., Dec. 18, 2023</font><font style="font-size: 10pt;"> &#8211; Ionis
          Pharmaceuticals, Inc. (Nasdaq: IONS) <font style="font-family: 'Times New Roman';">today announced that it has entered into a license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) under which Otsuka obtains exclusive rights in Europe to commercialize donidalorsen, an investigational prophylactic treatment for hereditary angioedema (HAE). Ionis will
            maintain responsibility for the non-clinical and clinical development of donidalorsen, and Otsuka will be responsible for European regulatory filings and commercialization.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ionis plans to independently launch donidalorsen in the U.S. if approved, as part of the company&#8217;s strategy to deliver a steady flow of wholly owned medicines
        to patients.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;We are excited to collaborate with Otsuka given their proven results in bringing rare disease
          medicines to patients in Europe,&#8221; said Brett P. Monia, Ph.D., Ionis&#8217; chief executive officer. &#8220;This agreement is aligned with our strategy to initially focus our commercialization efforts&#160;on the U.S. market. We are encouraged by the strong product profile of donidalorsen to date and look forward to reporting pivotal
          topline Phase 3 donidalorsen results in HAE in the first half of next year.&#8221;</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Otsuka brings expertise in delivering rare disease medicines to patients, a robust commercial infrastructure, and deep knowledge of regional and local
        regulations across European countries. As part of the agreement, Ionis will receive a $65 million upfront payment and milestone payments based on achievement of regulatory and sales targets. Ionis is also eligible to earn tiered royalties ranging
        from 20 to 30 percent (based on aggregate annual net sales).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Makoto Inoue, president and representative director of Otsuka Pharmaceutical Co., Ltd. commented, &#8220;Otsuka has developed drugs in Europe for rare diseases such
        as autosomal dominant polycystic kidney disease (ADPKD). Through this collaboration with Ionis, a leader in RNA-targeted therapy, if regulatory approval is received<font style="font-family: 'Times New Roman';">,</font> we look forward to
        bringing donidalorsen to patients in Europe to address the unmet medical needs of patients with HAE.&#8221;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ionis recently reported two-year results from the Phase 2 open-label extension (OLE) trial showing that donidalorsen treatment resulted in a 96% overall
        sustained mean reduction from baseline in HAE attack rates and was recently granted Orphan Drug Designation in the U.S.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Injection site (IS) discoloration and IS reaction were the only study drug-related treatment-emergent adverse events (TEAEs) reported in more than one patient
        (n=2, 11.8% each). No serious adverse events were reported in the OLE study, and no TEAEs led to study discontinuation. The company plans to report Phase 3 results with donidalorsen for prophylactic treatment of HAE in the first half of 2024.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Hereditary Angioedema (HAE)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">HAE is a rare and life-threatening genetic disease characterized by unpredictable and frequently severe swelling of the skin, gastrointestinal (GI) tract, upper
        respiratory system, face, and throat, which can be life-threatening.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1-5</sup> HAE is estimated to affect more than 20,000 patients in the U.S. and Europe.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">6</sup> In the U.S., doctors frequently use prophylactic treatment approaches to
        prevent and reduce the severity of HAE attacks in patients.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Donidalorsen</div>
      <div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Donidalorsen is an investigational <font style="font-family: 'Times New Roman'; font-weight: bold;">LI</font>gand-<font style="font-family: 'Times New Roman'; font-weight: bold;">C</font>onjugated <font style="font-family: 'Times New Roman'; font-weight: bold;">A</font>ntisense (LICA) medicine designed to target the prekallikrein, or PKK, pathway. PKK plays an
          important role in activating inflammatory mediators associated with acute attacks of hereditary angioedema (HAE). By reducing the production of PKK, donidalorsen could be an effective prophylactic approach to preventing HAE attacks.</div>
        <div style="font-size: 10pt;">&#160;</div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Ionis Pharmaceuticals, Inc.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four
        marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the
        leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">To learn more about Ionis visit </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">www.ionispharma.com</font></u><font style="font-size: 10pt; font-family: 'Times New Roman';"> and follow us on Twitter @ionispharma.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis' Forward-looking Statements</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This press release includes forward-looking statements regarding Ionis&#8217; business, and the therapeutic and commercial potential of donidalorsen, Ionis'
        technologies, and other products in development. Any statement describing Ionis&#8217; goals, expectations, financial or other projections, intentions, or beliefs is a forward-looking statement and should be considered an at-risk statement. Such
        statements are subject to certain risks and uncertainties, including but not limited to those related to our commercial products and the medicines in our pipeline, and particularly those inherent in the process of discovering, developing and
        commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis&#8217; forward-looking statements also involve assumptions that, if they never materialize or
        prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis&#8217; forward-looking statements reflect the good faith judgment of its management, these statements are based
        only on facts and factors currently known by Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form
        10-K for the year ended Dec. 31, 2022, and most recent Form 10-Q, which are on file with the SEC. Copies of these and other documents are available at <u><font style="font-family: 'Times New Roman';">www.ionispharma.com</font></u><font style="font-family: 'Times New Roman';">.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ionis Pharmaceuticals&#174; is a registered trademark of Ionis Pharmaceuticals, Inc.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1. Manning ME. Dermatol Ther (Heidelb). 2021; 11:1829-1838.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2. Valerieva A, et al. Balkan Med J. 2021;8:89-103.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3. Santacroce R, et al. J Clin Med. 2021;10:2023.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">4. Pines JM, et al. J Emerg Med. 2021;60:35-43.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5. Maurer M, et al. World Allergy Organ J. 2022;15:100627.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6. Weller K, et al. Allergy. 2016;71(8): 1203-1209.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis Investor Contact:</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">D. Wade Walke, Ph.D.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">info@ionisph.com</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">760-603-2331</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ionis Media Contact:</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Hayley Soffer</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ionis_ca@ionisph.com</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">760-603-4679</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ions-20231218.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.12.1.5186 Broadridge-->
<xs:schema targetNamespace="http://ionispharma.com/20231218" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:ions="http://ionispharma.com/20231218" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ions-20231218_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ions-20231218_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://ionispharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ions-20231218_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.12.1.5186 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ions-20231218_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.12.1.5186 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://ionispharma.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="ions-20231218.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://ionispharma.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +U!5 # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_,T5G[IGFU2U!GJ%%%%<)\@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]I6=@HHHK(X HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 444$X% #)'$:,Y/09KPSXA^(3?:E+9H<!3UKT+QEXFAL+22%9,28(XKP*Y
MGDN;J2:0DLS'FMJ<=;GT.3X-M^TD1[.<FFA< BG'(;/:D-=:9]2TD,Q\I/I2
M;.*"#@TWYL[1U/2FR9RLBYI5BU_J<-N.YP:^DO"^CKI.EQP]P/Z5Y=\-?#4C
MS?:YH\CJ":]M4!5 KDK2Z'R.;8GGGR(=1116!XH4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***"<#- $-S<);Q%W8 "O%/B)XE_M&9;6(\+Q
MD5UGQ!\2):1-9HQWL.H/M7C<\C7$WF,<FMX1ZGTF38"]JTB(1\<FAER,>E.V
MDTA!VX]*W1]996(R,#-'&,>E(0<9II!R%'6B^IG)I$UM;27UTD:*22<5[OX$
M\*#1;!2XRS8;FN(^'7AQKFZCO'4%%/<5[6JK%$ . !6-6?0^3S?&N4O9Q(+Z
M\BLK9I'8* .]>&>-/$QU2[,*'Y4..*ZKXC>(@(/L\3D-TX->2'<SEF.2U*DC
MJR? 62JS% _2NH^'UM]J\0?3!_G7+X(4BO0?A39D:NTQ'!']#6DWH>KFD_9T
M'8]J08C4>@%.I!TI:Y#X!A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#W_(ZO\ ]<:^@J^?O@]_R.KG_IC7T#7GU_C/C\V_WEA1116)Y@4444 %%%%
M!1110 444R658HR[$ #UH#<JZE?QV%JTLC   U\]^-?$T^I:C*D4Q,.< 9KI
MOB%XTD%S)9P,"G(X/O7E98R.S-WYKJHT]+GT668/E7/-#,?Q#J:!2]J*[%L>
M^HI;"C-(:4&C.>*16EA!THYH/!QZ49H$'O1R3BCM0#@YI] "@444#%I**.]
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MI)ZGDYA@XU8W6Y]0YS16-X?UF'5K-7C?/%;-<+5G8^6G!PERL****1 4444
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M_(Z/_P!<:^@:^??@]_R.K_\ 7&OH*O/KOWSX_-_]Z84445B>8%%%% !1110
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M^*6#:Q?3_&O%T4+G%>S_ !4&;6(^W^->,HI*Y[FNFG\)]MDMEA4Q\<332HB
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MG@[)%<?PG->Z_#+7ENM/%N\F7X S7-7@K7/ S?#:<Z/2J*0'-+7&?.!1110
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M"*]:^$6N&-GL))/E/(!KR@CG%:_A74CI6N1S9X8A:RK1YHG%CJ"JT6CZH!R
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M@-U(O+C(_2O6.U8WAK3ET_2((PN"$P:V:\VI+FD?$XJK[6JY!1114',%%%%
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MG%;7A+X>X=9KE0R\'FO6K"P@L8%C@0*H':N2K5Z(\''9A;2#,#2/"L6GPJI
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MXPQM.,?C7,V5JUW>1PKW->N:38QV-HJ(N,@9KV<JPW//F9X^:XGECR1ZE\#
MP*6BBOJT?-A1110 4444 %,EYB;Z4^F2_P"K:FMQK<^5?$__ "->H_\ 74UE
MUJ^*/^1LU'_KJ:RJ].'PGW>&_A1#VHS115&X=J***  T4H(P<TE+J(6D[TM)
MUIC._P#@]_R.K_\ 7&OH*OGWX/?\CJ__ %QKZ"KSZ_QGQ^;_ .],****Q/,"
MBBB@ J&[.+*<^D;?RJ:JNI/Y>G7!_P"F;?RIK5CBKNQ\IZG<?:-5NL]I6'ZU
M3!YJ6Z&W4KOWE;^=1UZ4%[I]UAU:F@S1VH%%6= 9HHH[4 &:.U%% !FC-%%
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M***ZSF"BBB@ HHHH *9-_JF^E/IDO^K;Z4UN-;GRKXG_ .1KU'_KJ:RZU?%
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MBF,,4444 %%%'- !11VHH **** "BBB@!<<4GO2]J0TAL ,G%!X.*49!I.]
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MQ7B_PXTHWVLQ3%<H#SD>]?0T$8BB5 , 5Q5Y7/F,WK7ER(DHHHKF/#"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"GJ5JEW92QLH.4(KYH\8Z6=(UZ1%4
MA6);I7U$>1BO'OB_HWR)?HHQG;P*WHSL['J977Y*O+W/(.U*#@YIN><4M=Y]
M:G= 31110,,T44=J #-%&:*!BDEL>U)G!H[4H/RD4=!,]!^%5]Y&HRH3C<3C
M]*]^7E17R[X,O#;>(K5,D;GKZ@C.Z-2/2N'$*S/D\VARU4/HHHKG/)"BBB@
MKB/B4/\ B1G_ ':[>N'^)?\ R!#]*NG\2.C"?QHGSHAX/UIU(O3\:7M7I+8^
MYC\*#-%%%,H,T444 %&:*7WH 2C-%'>@ HHHH$+2>U+1GF@;V$I>II<C-(*!
M("W-)1WHS20P4X;Z5-;SO:7L5Q&2"ISQ41Z49&TYH:NC.4>969](^!-<_M72
M8][ OCD9]JZ^O _A=KOV751;.QVL, 9KWL'(R*\^K'ED?'8^C[.L_,6BBBLC
MA"BBB@"">V29U9AG%/8K%&3P *DKGO$6KI9V[+GG!%85IQI1<V;4H2J244<K
MXMUN2:X:U0_*I[&N5R>IJ264SS-*QSDU'D;2*^+Q5=U9ML^LPE%4H60#IFE!
M^4@]Z3(;IVI6(P*YF=:NMQ#P,^E:N@Z<=0NLLIV@^E9<2F641 <MQ7I_A;21
M9V2EU&XCTKTLOPKJU-3S<PQ*IPTW-JPLX[.V6-0.*Y7QWXF_L?3W$3CS&!!&
M:ZN^NDL[5Y6.-JDU\X^-=?;5M5F*.?+S@#/O7VN'I*UCQL#AW7J<TMCG]0OY
M=1O'ED8G))KN/A5_R&X_K_6O/ND9'>O0?A7_ ,AJ+Z_UKMFK09[^,@H8=I=C
MZ HHHKSSXX**** "BBB@ IDO^K;Z4^F3?ZIOI36XUN?*WB<_\59J/_74UE9K
M4\3_ /(UZC_UU-9=>G#X3[O#?PHA1FBC-4;A11VHH 7=@$>M)0:*.HA:04M)
MT- SO_@]_P CK)_UQKZ"KY]^#W_(ZO\ ]<:^@J\^O\9\?F_^],****Q/,"BB
MB@ JEJR[M,N/^N;?RJ[4%Z-UC<#_ *9M_*FG9W*B[23/DBYXU"Z_ZZM_.FEL
M@>U2W\9AU2[4]Y6_G4->E#8^YP[O304=Z.E%6= 9H[4OO24 &:**.U !FBC-
M%  .#FG;N]-I<\4- A\%Q);S+*C$%3GBO3O"?Q#N#+%;3, O R37EQI1(\1#
MQD@CTK.4$]SCQ6%A56J/JRRU>VN(U(E4Y'K6BKJXRIS7S9H7BZ6R 261C^->
ME:1\0[9E1&)S]:XYTFMCYJME\XZQ/2Z*S;#5H;R,.K#GWK1#*W0@UDTUN>?*
M$HNS%HHHI$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!\?<44=Z*]8_0PXHHHH ***.] "G&WWI.*2E[TA(6DHH'6F,]:^!_^LO_
M *G^E>SUXS\$/]9?_4_TKV:O-J_&SXK,?]YD%%%%9G"%%%% #)6V1,Q["OF'
MQM/YWB.ZY_Y:'%?2^H-LL)F]%KY9\0R^=K]V?^FAKIPZ/;R:/ON1G=!0*<0-
MH--QS7;T/J!>-OO12'K2TD 'I0<4=J2FQ/<**4]*4@;,T(;$;VZ4<;<=R<"@
M=*?;PF>\AC R2XX_&D](D5'RQN>W_"C1/LVEF>5?G)R./<UZ=61X=L5L-)MT
M48S&I/Y5KUYDG=GP^)J>TJN04445)SA1110 4444 %%%% !1110 4444 %%%
M% !1110 5S'CC3$U+09(V7.T%A73U5U&$3V,R'NA_E3B[,UHSY*BD?)T\'V>
M\FC<='('YU"1U/:M_P 7V7V/6I%QC+$UA#GY?6O2B_=1]OAY<]-,;VHI2.WI
M259N'%%%% !Q11BCM0 4444 7M&<0:[:2]E;)KZCT:Z6\TZ.53D$5\HQ/Y=P
MC^AKZ6\ 3_:/"UN^<Y_P%<F(1\YG4;-,ZBBBBN0^?"BBB@ KA_B4/^)(?I7<
M5Q'Q*/\ Q)"/45=/XD=&$_C1/G1#D'ZTM-7@?C3J]);'W,?A0<444=J90<44
M8HH *7O24&CH II.*4>M)WI(&+QBD'6C'%+BFQ)!FDHH[4##BBCO10 <4<4=
MZ.U #CC*X_&FMUI<<4J@$&@5K%S2+YM,U*"Y4XVN"?I7TMX7UJ/6-+CF5LDC
MU]J^6B-PQ7J?PM\0M#<"P=@$7&,GVKGK0YE='BYKAN>/,NA[?1348.@8=Q3J
MX3Y<**** *&J7JV=J[$X..*\KU;59=0G92V5S7;^,Y2ENH'<5YL!@[NYKYK-
ML5)2]FCW\KH1Y>< 0..U'&:<Z#;FD ^7/>OGSWEHA" &^7I0,$X[]J7OBM#1
M]/-[?*N"5S6U*FYR21G6J*$6V;GA;0//D\Z9>!R.*]"^2UM_15%5]-LUM+=5
M [5SWC77UTRP95<!R.F:^TP&%5.*1\K5G+%5N5''?$7QML1K.SD^?HV#VS7D
M+-YDC,W?FI]1NWU"^>X<\L:K[0&(KW(044?38/#*C"PPUZ%\+/\ D.18]?ZU
MY]V->@_"O_D-Q?7^M%7X6&8?P)'T!1117G'Q04444 %%%% !3)?]6U/IDW^J
M;Z4UN-;GRMXHQ_PEFI?]=365Q6IXG_Y&O4?^NIK+KTX?"?=X;^%$*.*.U&*H
MW"BBB@!1C!S24&BCJ(6DZTM(.M SO_@]_P CJ_\ UQKZ"KY]^#W_ ".LG_7&
MOH*O/K_&?'YO_O3"BBBL3S HHHH *CG&ZWE'JA'Z5)2,,HP]10"/EOQ?9_8M
M<E4C!9R:Q3C _6NV^*5KY/B5<#@@G^5</W(KT:;]T^WP3YJ28444=JU1V"]J
M2@<\4=J2!AQ1113 .**** "EI*7VH 2ER,8[44,,4"8S;SD58AO)(&!1CD5#
MVHV#(I-(B44=%8^.=4M6"+(VT>]>B^&_B1$%"WTOS8[FO%M@#9IQ#;@P8BLY
M4DSSZV7PJ]#Z?LO&&GWV/+D4Y]ZVXKJ.505(Y]Z^7-.\03Z<PVL>/>NST3XB
MW+.$D( 'J:YY4$CR:^5\GPGNP(-+7#:=XQBFVAY5Y'J*ZJVU2VG0$2J2?>L'
M!H\RI0G#=%^BD5@PR#2U)B%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!\?8HHYHKUC]##%%%% !1BBB@0%>,T49/2BD M)WHH%,;/6_@?\ ZR_^
MI_I7LU>,_ __ %E_]3_2O9J\VK\;/BLQ_P!YD%%%%9G"%%%% &;KTGEZ+=-G
M&$KY8U$F35+A\]6KZ:\7R^7X=O#G_EF:^8)26GD;U-=>'6A]%DL/=;&4OM28
MXI:ZSZ% 1QFD]J">U%(!:0BB@G-,3"CM110-B]#BM_P59_;_ !7;1XR,YKGB
M3UKT7X3V/FZY%<[>%[UE4=HG%CJG)1;/>8$V6\:?W5 J2@=**\X^)84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !2.-R$>HI:* / OBM8&WUM90
M/EQZ>PKSSMGUKVSXM:>7L7N]O"CK^%>(*25%>A1=XGV&5U.:BAU&*#16QZ88
MHHHH$&**.:*!A2TE+0"&29\LD5]#?"N??X1MXR>1_@*^>V_U;"O<?A+/G2XX
M<]!T_"N:NM#QLWIWI\W8]0HHHKB/E0HHHH *X?XE_P#($/TKN*XCXE?\@-O]
MVKI_$CHPG\:)\Z+R/QI>U-3I^-.KTEL?<Q^%!BBBBF4&**.:* "C&:*6@0=J
M2CM10.XM'?ZT"DYH87T#H:,4IY'TI*2$G<,4=J**8!BBBCM0,4=<>M'0XI.:
M*$)@1WJ]HE^VG:E'*&(^89P:HX.?:@C!SW%2UH9U(*<;'U-X6U1-4T>.5&S@
M 'FMNO'?A'KPV-82R?/G(!KV$'(!]:\^I'ED?%XRC[*JT+11169RG(>-O]0I
M]J\Y3N3WKT7QQGR$],5YTIX]J^1S=?OV?494OW*!02,9IR\#=V%)R#FD?)(Q
MTKR;79ZMQ886N)=JCK7I'A;1S;1>9(HR>G%8?AC1VDE65TRM>@C9;6_H *^C
MRK!_;D?.9CBG)^SB0ZC?1:?9O,[ !1GK7SSXW\2'6=3?R7.P'IFNK^)/BDN?
MLUM*1V8 UY1RV6/7O7UE"G8Z<KP=OWDAH&.:49)I.?PI0"#BNJ_0]Y"=C7H/
MPJXUN+Z_UKS[GFO0?A7_ ,AN+Z_UK.K\!QYA_ 9] 4445YQ\4%%%% !1110
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MH2?[HKFQ"]T\+.&_96.KHHHKB/F0HHHH **** "BBB@ HHHH **** "BBB@
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M!(*2CO2G@UMU.VXE!I:4 $U-QL;VKT'X5_\ (;B^O]:\^/0UZ#\*^-;B^O\
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M?%!1110 4444 %,E_P!6WTI],EYB;Z4UN-;GRMXG_P"1LU'_ *ZFLJM3Q/\
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MHF,\\?UKEK['B9O']S<[VBBBN,^7"BBB@ HHHH **** "BBB@ HHHH ****
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M-U "4IP1Q^-![THP"/?K2Z$R5S6M==GM;)X4D(!& *R6D:8^8YRQZTA +4$
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MG<BGU%.JIILPGT^"0'K&#^E6Z\QGP\E9V"BBBD(**** "BBB@ HHHH ****
M"BBB@ HHHH **** "@\#-%17,@CMI'/92:!K5GC7Q=OS]K^SJWRD<C\*\HP<
M 5UWQ U+[?KK 'A217)[OF'M7I4E:!]EE\.6BD-HI3U^M)6B/0"BBB@0<T49
MH[4#"@49H]:0#7XC)KW[X408\.0S8Y/?\*\#VF3"#J:^D/AI;F#PA;J1S_\
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M./B@HHHH **** "F2_ZIOI3Z9+_JV^E-;C6Y\J^)_P#D:]1_ZZFLNM7Q.?\
MBK-1_P"NIK*KTX?"?=X;^%$*.:.U&:HV"BBB@ Q1VI0V 1ZTE+J M)WI:04Q
MG?\ P>_Y'1_^N-?05?/OP>_Y'63_ *XU]!5Y]?XSX_-_]Z84445B>8%%%% !
M1110 4444 %%%% !1110 4444 %-= ZD$#FG44 <IK7@NPU+=+)&"WTKS#6_
M KP2/]F@./85[UUJ&2VBD!!4<U<:C1V4<;4I]3Y5NM"O+>1@\3 "L^5'BX<8
M-?2VJ^$XKT,0 ,UP>L_#5I TB$\5V0K(]RAF--[L\B!].E.KH-4\*WFGY5(F
M;\*PVM;J//F0LN/45ISI['H0Q,9;,9VXHSD8H5@.#WHZ-5)G5<3&**4G+9I*
M8!11GFB@ HHHH&%%%&>: "BBCO0(***6@8E*:0=** #)%"DB>)O1P?UH-)[^
MG-)ZJQ$U>+1]1>$+[[=HD+;L[445T%>:_"74?/T1D8\@X_4UZ57FS5I'P^)A
MR56@HHHJ#G"BBB@#X^[T=J.]':O6/T,,T4<44 %'>BCO0 E+2G&T>M)WI"%I
M!UI:2F,];^"'^MO_ *G^E>S5XQ\#_P#67_U/]*]GKS:OQL^*S'_>9!11169P
MA1110!#=+NMW'J*^7O%L?E>(;OCK(:^IF&Y2#WKYI^(5KY'B"=L8#25T4'K8
M]C)YVJ-'*@\4H.*04O%=W0^JW"@T<;<]\T4KC6PG:BBBF(*4<4E':@& /-&<
M2(WHP-'>@_=I/56"2O%H^D?A]K":IH2L#]P!:["O$/A1J_V=Q9E\*QZ?C7MR
MD$9%>=4C:1\3CJ+I56A:***S.,**** "BBB@ HHHH **** "BBB@ HHHH **
M** "L7Q1>BRT6:0G&5(_2MJO._BMJHM-$$*OAV;I505V=&%ASUHQ/#=3N?M-
M_.^<_.?YU4I>&+,>I.:7 R*]*.D;'VU*/)%(3-)2GK24T:L*.U%':F 9HHXH
MH />E!ZTG.*!2%N6M,B\_5K:+^\V*^H/#5K]CT:*+&,#^E?-?AB$S>)+/ R
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M@(#;3UH!P35)G6I7V$SSBEHQSFG #FFV-7&T=Z*.]!0=Z<Q&:3M24""C-%%
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MA_ 9] 4445YI\4%%%% !1110 4R7_5-]*?3)?]6WTIK<:W/E7Q/_ ,C7J/\
MUU-9>*U/$X_XJS4O^NIK+KTX?"?=X;^%$*,448JC<,4444 !HI=N03Z4E'40
MM(.M+2>] SO_ (/?\CK)_P!<:^@J^??@]_R.K_\ 7&OH*O/K_&?'YO\ [TPH
MHHK$\P**** "BBB@ HHHH **** "BLO^V(1J#6I8;A6F"",BBPW%K<6BBB@0
M4444 %%%% !1110 4444 %)M!/-+10!7FM(Y5P5%<SK?A*/48F"C!(KKJ3'-
M4I-&M.M.&S/GWQ'\/)]-62:(,_). *X2:WEMV*RH5(]:^MIK.&X4K(@8>XKR
MKQSX%>YF:XMD"J!T KHA6OHSV\'F?V9'CBG(I<?I4U[8R6$YB<'(.*@()Z=J
MZD[H^@C44HW0'IFBDH[52+0&C% HH ,4444""C%%% !0.#10: L==\/I?+\0
MPKZ_XU]'6YS I]J^9_ YV^)(!_GJ*^EK/_CUC^E<.(W/ELX7[Q$]%%%<YXP4
M444 ?'W-%&:*]8_0PHHS10 4449H$&>,44E+2 *!2TG>F,]:^!_^LO\ ZG^E
M>SUXS\$/]9?_ %/]*]FKS:OQL^*S'_>9!11169PA1110 5S/C:S%SX?N21DJ
MG%=-5/4[<76GS0GHPQ51=F:49N$TT?)11HY&0CH:5AQCO6UXILAI_B&: #"K
MT_,UBY^;->C!W1]O1ES4TT)T&*.1103DU3W-UH*:2BC-,8449HH$%':C-% !
MR*Z;P+K<FCZXB[]L<A^:N9+=Z4.RL'4X(J6M+&%:G[2/*SZTTZ\2\M$D1@<B
MKE>1_#3Q89T-K<2 ;>%R:];5@ZA@<@UYU2'*SXW%4'1J.(M%%%0<P4444 %%
M%% !1110 4444 %%%% !4<\JPPO(QPJC)-2'@5P?Q'\2_P!DZ*4@<&20[2,U
M45=V-*5-U)J*ZG ?$;Q*U[=/;12;HP>,'WKSG!QD]2:?-</<S&1R23ZTQCFO
M1IQY4?:X6BJ5-)"Y[=J#DD4@I0<&K.H#249HS0@"BC-% @YHHS10,7FFMG%.
M)S2Q O.L>/O&A[$2=D>\_"VQ\G3!)MQN7/\ *O1JY[P;9K:^';3 P3&,UT->
M7-W9\/BI\]5L****DYPHHHH *XCXE?\ (#;_ ':[>N'^)?\ R!#]*NG\2.C"
M?QHGSHG3\:=2#[OXTO:O26Q]S'X4%%&:*90<T49HH ***,T"#!ZTH),D?^^/
MYTF?EQ0HQ+&?]L?SJ7L9U/A/IWP7_P @2+_<%=)7.>#!C1(O]P5T=>;/XF?$
M8K^-(****DP"BBB@ K \4Z4FIZ9)&R[CC^E;](RAA@BFG9W+IS<)*2/DS5[)
M[#4YHG4JH; JB21P*]8^*GAM866[A3KR<#ZUY0,D5Z%*7,C[+!5U6IW0<XQ1
MS1FC-:L[0/6EI*/>@8449HH$%%%% !11FCM0 449HH *.:*,T#"@$BBCK0(*
M]!^%?_(;B^O]:\^[5Z#\*N=;B^O]:RJ_"SBS#^ SZ HHHKSCXH**** "BBB@
M IDO^K;Z4^F2\Q-]*:W&MSY5\3_\C9J/_74UEUJ>)_\ D:]1_P"NIK+S7IP^
M$^[PW\*(4<T49JC8***,T &2.***.U'4!:04M)WH&=_\'O\ D=9/^N-?05?/
MOP>_Y'1_^N-?05>?7^,^/S?_ 'IA1116)Y@4444 %%%% !1110 52U2[6SL9
M)6;&!5VO+?BKXD>P@CM86Y?AL&KA'F9OAJ3JU%%'"ZIXRNT\4M)%*?++=<^]
M>U>%]=BU2PB(D#/M&:^8#ESO)^8FND\,^++K0[R)$8E"P!R:Z9TO=T/?Q>7J
M5+W=SZ=HK'T368=2LXG$BEV4$@&MBN1IIV/FYP<'9A1112)"BBB@ HHHH **
M** "BBB@ HHHH *@N8%N(S&XR#4]% T[.YX]X_\ "*1P/<V\7(&20*\?Y4E3
MU'6OK+5[-+S3IHF4'<N*^7_$%H+/6+B(# #XKMHSYM#Z;*<0YQ<9&;[T49XQ
M0*Z4>V HI:3-(84449IB"BC-% !SVH]J4-@TG>@#<\(R,GB2#'^>17TWIY+6
M,1/I7S%X3Y\20?Y[BOIW3?\ CPB^E<.(W/F<Z^-%JBBBN<\,**** /C[O11Q
M17K'Z&%%'%% !1WHHH 4D;<4G>D[TO%(044M(.M,9ZU\#_\ 67_U/]*]GKQG
MX(?ZR_\ J?Z5[-7FU?C9\5F/^\R"BBBLSA"BBB@ IKC<I%.HH ^>_B?9>1K;
MS8X+?UK@V.>:]I^+6E!M/6Z"\[^37BH(Q7H4G>)]EEE13HH7/RXI.])WI36R
M1Z 44=J.*!A11Q10 4=J.*.U  /6BER*!C!I(&6M,OY=-U"*9'*JIR<&OH?P
M?XIAUBQ4 _,!SDU\V$;OI71>&?$DVB3@*Y$9/K652FI(\C'X/VJOU/I\'(XI
M:Y'PQXRL]7C6$2 R]^:ZT'(R*X'%K<^6J4Y0=I"T444B HHHH **** "BBB@
M HHK(UG6[?2;9I)F XSUII-E0@YNR$UW6HM*M6=V[>M?/7B[7FUG4G8.3'G@
M$^]:'BKQG<:I<2)%(3%GCGM7%MDMFNRC3MN?2Y?@?9VD]PQ24_(V^]-[UTGM
MAVH'6@T4@"BBBF,**.** #-':CBB@ J_H</VG7[*$#.^0"J)P!GM7<?##1/[
M3U@7)7/D/D<?2LJDK(X\955.DV>_:=!]FT^&'^ZN*M4@&!BEKSCXEN[N%%%%
M @HHHH *XCXE#_B2$^@KMZX?XE'_ (DA^E73^)'1A/XT3YU0\'ZTM-48'XT[
MM7I+8^YC\*"CM1Q13*#-%'%% !1WHHH .].R#+&?]L?SI.-OO2)_K8_3>/YU
M+VN9U/A/IWP7_P @2+_<%=)7.>#!C1(O]P5T=>;/XF?#XK^-(****DP"BBB@
M HHHH PO%.F+J6CW$94%MG&17S+>VYLKZ:W<<JV*^M9$$B%&Z&OG[XD^'6L-
M2:XC3"R-GI730G9V/:RC$<LN1G! 9/TI.].##;QUIM=BU/J+]@[49H[4#K38
MP[444<4 %':CBB@ HHXHH .]%'%% !1FBCB@ [4JD TE!H$!Z&O0?A7_ ,AN
M+Z_UKS[M7H/PK_Y#<7U_K657X6<68?P&?0%%%%><?%!1110 4444 %,E_P!6
MWTI],E_U3?2FMQK<^5O%'_(V:C_UU-95:GB?_D:]1_ZZFLOBO3A\)]WAOX40
M[49HHXJC<**** %! !]Z2D-+1U$+24M)T- SO_@]_P CK)_UQKZ"KY]^#W_(
MZO\ ]<:^@J\^O\9\?F_^],****Q/,"BBB@ HHHH **** *FH7:V=H\K'A1FO
MF[QUK']KZ](RL2BG@5ZA\1_%*V=L;:)\,PP<&O#)',KF1_O$\UV8>'4^ARG#
M6_>,3.!BE)&T$?>'2D&,\TO&WWKI1] U=6.S\$>*WTJ[C2XD8KG&":]ZTS5(
MK^!75AR!7RB"4<2+VKN_"WCJ>RF2.>0B,<<FL*U)-71X>/P'-[T=SZ%HK%T#
MQ!;:U;[H7!*]>:VJXFFCYR47%V84444B0HHHH **** "BBB@ HHHH **** $
M(!&#7S/X^A\KQ'<G'!DKZ9KYQ^)#1G7I0OW@_-;T/B/6RAOVS.,[TOO1]:*[
MT?6V$H[T4<4 %%%'% !11Q10 4=J.**!&[X.3=XE@/\ GJ*^F[#BRB^E?-/@
MD ^)(/3_ .N*^F++_CTC^E<.(W/F,Y^-$]%%%<YX@4444 ?'W>CM1BBO6/T,
M,448HH *.]%% "D#:#2444A"TE% ZTQGK7P/_P!9?_4_TKV>O&?@?_K+_P"I
M_I7LU>;5^-GQ68_[S(****S.$**** "BBB@#D_B!8_;?#DPQDHI-?-9C*.RM
MQ@U]:ZE;"[TZ>#&=Z$"OF'Q5I[Z;K\UN5P!_C75AWT/H,FK))P,?%+CFD%+C
MBNP^C0G:B@T4( H[444""C%%% "L,'BCH,T8(X-&."?2ET!"C^=(R@@C/2CM
M0 3FAZL'%&EH&NSZ'=B:,DY->\>%?%\>I6<;3R*&(Z9KYSVU=T_5+FRF&V5@
MH/0&L:M+F/*QF 5571]60WD,P^5P?QJP"#TKPS0_'Z6^Q968X]37>Z=X[M)]
MJ[NOO7-*DT>#7P$Z>VIV]%9-MKMM<#B1?SJXM_;M_P M4_.L^5G&Z<ENBU15
M9[ZW7_EJGYU6FUBVB7)E7\Z7*PC3E+9&E43SQQCYF _&N4OO&]G;%AN!Q[UQ
MNL_$.%E?RV/IP:TC2;.FE@JDWJCNM<\3P6-L[)*FX=MU>*>)_&USJ[R6['Y1
MP,5B:IK5S?7!(E;:3TS67CYLGD]ZZHTDCWL)E\:>KW%4;1USFE]J",'/K2&M
MD>O'1#L# H9<'BDVG&<TX\+CO0-#.M '.*6DH&P-%'6BF(*.U%% !BBCK1VH
M&(>?E]:]\^%NC)I^GM.!S*,_RKP_2K-K_48[=!DDU].>&K+[%HUO&1@A>:Y:
M[T/!SBK:')W-JBBBN,^:"BBB@ HHHH *X?XE_P#($/TKN*XCXE'_ (D9_P!V
MKI_$CHPG\:)\Z+R#]:7M34X'XTZO26Q]S'X4%%&**90448HH *,<T44 '>G8
M EC_ -\?SI,?+FD4YEC'^V/YU+V,JGPGT]X,.=$B_P!P5T=<WX+_ .0)%_N"
MNDKS9_$SXC%?QI!1114F 4444 %%%% !7)^.="CU729)",M&O'%=94<\8FA:
M-AD$4T[,NG-PFI(^1[JV>UN&C<$$'O48YKO/B3H#V&H-=*F(V; P/>N!' KT
MJ;NC[;#5?:4TQ:,<T>]%6=(4444#"BBCM0 4=J** #'-%&** "BBC% !3E )
MIM'2@0'H:]!^%?&MQ?7^M>?=J]!^%?\ R&XOK_6LJOPLXLP_@,^@****\X^*
M"BBB@ HHHH *9+_JV^E/IDO$3?2FMQK<^5O%'_(V:C_UU-95:GB?_D:]1_ZZ
MFLO%>G#X3[O#?PHA1BBC%4;AVHHHH 4 $&DHHI=1"TGO2T@ZTQG?_![_ )'5
M_P#KC7T%7S[\'O\ D=9/^N-?05>?7^,^/S?_ 'IA1116)Y@4444 %%%% !5/
M4KQ+*RDE9@ !WJY7FGQ3\1)9:9]DC?\ >2CL:N$>:5C?#TO:5%$\G\6:L^JZ
MS-N.51N*PV P#ZTUB68NQR6ZTI!('O7H15M#[6C35."2$HQ2A#G&:4'!JF;
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M<1N?*9N_WMAU%%%<YY 4444 ?'U%%%>L?H8<T49HH$%%%% !@XS12[N,4E)
M+2=Z**8V>M_ _P#UE_\ 4_TKV:O&/@?_ *R_^I_I7L]>;5^-GQ68_P"\R"BB
MBLSA"BBB@ HHHH *\:^+.BA5-ZD8W,>3^->RURWCC2UU+1G4C.U2:TI2Y9'7
M@:GLZR9\S8/Y4X9Z5+=PF"[EB(QAS4.[:<UZ*U5S[6$KQN*:2C.?QI:9>XE
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MU^$^C>1I!N74AF;(R*]-KSZLKNQ\AF5;VE;3H%%%%9'G!1110 4444 %</\
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MRJ_"SBS#^ SZ HHHKSCXH**** "BBB@ IDO^K;Z4^F2_ZMOI36XUN?*OB?\
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MZ"$[44=:!UI)#9ZU\#_]9?\ U/\ 2O9Z\9^"'^LO_P ?Z5[-7FU?C9\5F/\
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MZU](>&]'31M*CM@.5'7\*Y*U3H>'FF,Y5R1ZFO&@CC51T Q3J**XSYH****
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MYR4G)W84444B0HHHH **** "BBB@ HHHH **** "N'^)7_($/TKN*XCXE?\
M($/^[5TW:2.C"?QHGSJF2#]:*%X4_6BO23T/N8Z(6BDH[4RKBT4G-%(+A11V
MI13Z!NQO.:<@_?1_[X_G2&G+]^/UWC^=#V(GI%GTYX,_Y D7^X*Z.N;\%_\
M($B_W!725YE3XF?#XK^-(****@YPHHHH **** "BBB@ HHHH **** "FN@="
MIZ&G44 > ?$KPZ;&_:YC7"NV:\]!SS7TEX[T5=2T>9@FZ15XKYPDMY+69H90
M0P/0UWT9WC8^LRO$\].S&\GI2#B@$BBMCUEW%HI**8[BT4E'-(+BTG>BEI@'
M(6O0/A5_R&X_K_6O/B>*]!^%7_(;B^O]:SJ_ SAS#^#(^@****\T^*"BBB@
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M&^$HM,M(GD0>8!UKN*9&@C0*!P*?7!*7,[GR%:JZL^9A1114F04444 %%%%
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M* *0MM/2DV1>VX;L<5-!;SW3!8XRV?2K&CZ3-K-Z(8U(KV7PIX&^P^6\Z*W
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139964040372832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 18,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IONIS PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000874015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0336973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2855 Gazelle Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Carlsbad<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">931-9200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.001 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IONS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ef20016866_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ions-20231218.xsd" xlink:type="simple"/>
    <context id="c20231218to20231218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000874015</identifier>
        </entity>
        <period>
            <startDate>2023-12-18</startDate>
            <endDate>2023-12-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20231218to20231218"
      id="Fact_637afafd24c845dda43b8d058a1c395c">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20231218to20231218"
      id="Fact_10fa7a005dce489587912448509cfd59">0000874015</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20231218to20231218"
      id="Fact_23b73c8d977446e8b79798ca025c5831">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20231218to20231218"
      id="Fact_3cd79732e299404b8ec4908d412a98ed">2023-12-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20231218to20231218"
      id="Fact_e59de8cd1a8849acaca64b66459a21e0">IONIS PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20231218to20231218"
      id="Fact_bb6244741abf444aac7d588413d5b20f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20231218to20231218"
      id="Fact_83e97852a88e4f4fbe696a96cb31bbf3">000-19125</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20231218to20231218"
      id="Fact_5a98d6769c444caeb03fbfbc6529abd2">33-0336973</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20231218to20231218"
      id="Fact_638a5a277a0248bab88de621964c4eba">2855 Gazelle Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20231218to20231218"
      id="Fact_025c224f7ec9473f950212789c5f7e70">Carlsbad</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20231218to20231218"
      id="Fact_058b40592ef34728a498368f41bae1f4">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20231218to20231218"
      id="Fact_f9ab4efc9be64341a96874e8d1f36b8a">92010</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20231218to20231218"
      id="Fact_b708c5f80c3e40f680249eddfe0c91cf">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20231218to20231218"
      id="Fact_5cec64638b4e47e9a22af06a234c10b8">931-9200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20231218to20231218"
      id="Fact_dafa55dc224f44daad9dc3a09daa8219">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20231218to20231218"
      id="Fact_32b1206aa0f74514ad9952ed255e1951">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20231218to20231218"
      id="Fact_38244749a2c5401ca2a7d6a217c2b876">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20231218to20231218"
      id="Fact_160fcfdf1d1e4760999c48b63c926873">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20231218to20231218"
      id="Fact_aff3de112578476f82d62bab7ade63bc">Common Stock, $.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20231218to20231218"
      id="Fact_1ea1212e10d34e84983765112731d383">IONS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20231218to20231218"
      id="Fact_70a6b61e823e4e8a8ba368f1fccb69d8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20231218to20231218"
      id="Fact_6e6884befc9548299c4b8322b6a439c1">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M;(&25^F';+A3!   D1   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R=
MF&UOHT80Q[_*BE95*SF!Q<^I;<DAR9UU>7"#[TYJU1=K6-NK ,LM2YSTTW<6
MV^#>X<'JFY@%YL^/V>$_NQEMI7K)-IQK\A9'23:V-EJG5[:=!1L>L^Q2ICR!
M*RNI8J9AJ-9VEBK.PB(HCFS7<7IVS$1B34;%N;F:C&2N(Y'PN2)9'L=,O5_S
M2&['%K4.)Y[%>J/-"7LR2MF:^UQ_3N<*1G:I$HJ8)YF0"5%\-;:F].K:[9B
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " !L@9)7F5R<(Q &  "<)P  $P
M            @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M &R!DE?IAVRX4P0  )$0   8              " @0P(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " !L@9)7GZ ;\+$"  #B#   #0
M            @ &5#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &R!DE>7
MBKL<P    !,"   +              "  7$/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( &R!DE<<.&7J/P$  #P"   /              "  5H0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " !L@9)7)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " !L@9)799!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20016866_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ionispharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20016866_8k.htm">ef20016866_8k.htm</File>
    <File>ions-20231218.xsd</File>
    <File>ions-20231218_lab.xml</File>
    <File>ions-20231218_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20016866_8k.htm": {
   "nsprefix": "ions",
   "nsuri": "http://ionispharma.com/20231218",
   "dts": {
    "inline": {
     "local": [
      "ef20016866_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "ions-20231218.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ions-20231218_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ions-20231218_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://ionispharma.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20231218to20231218",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20016866_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20231218to20231218",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20016866_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ionispharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-23-058152-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-058152-xbrl.zip
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M$V;TK( B[LS!@]..A<C95::72E U&AJ#>PZA)VQ6U-Z0TG7C<^ N,MJV"F*
M1N:0PML^.UEW935<NZVPA+$B00CG[*_3'08E*8)BD2>&/$#.5Q[@) 0^0TS4
M@$%YU;(9I^(][N=D,->BBDJMV$)/6JY(,=S,!3Q>.;NW&:L9%#KWT0F* T"
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MM/_ _(XO<5LU4=-J4]NI4K=.W2;M;2(8)V@8/"!M\N\'V#C.=7&\O6'.^2[
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MV$LY(/R :_LEP"^F3BGV >BA4#%!.=3DK0\E(V<O?= ]C>]\4*6S[%*;-_6
M3G #B'WA9 ++JMW;'K3,]BGC+[J*;AY(#/_MC"E<3$8/-R!.-7-%G<'71!XH
MGV6M*&ONQ5\3&#>&5"^F3**J%#3"#AT\48^##665,/'F]WR@"BFF<#$I/=SD
M67K%S-F3]+"O\3EZ2#[+/B*R1!/OI_G/2(@._"2]:7=(]8K*6*K*W3/TH$/[
M6%Z1>^KS%Q?>/:_G) (>@;0HBJF!B@9\ GZN$#5;FR@U9<RN""HB* _UX$%)
MVUZ16HLKTPJ(!;!&G_:9E3I6^ %CQ:246 -")2=7;$*F)BIU[4R&\; <PKM
M*A9/9D^2">J W.Y.W>?;X(%M!@8>B+%)E%.X+'%P&B\;NCZ5 ]Y5IW,M928B
M2(1Z\$",=<-(O06&S^QEM7IVUYV*=SB6UN*2?>)O_BV:POQ-N;/_ 5!+ P04
M    " !L@9)7B32E&-T%  #X/@  %0   &EO;G,M,C R,S$R,3A?<')E+GAM
M;-5;75/C-A1][TS_@YL^)\9.EP)#=H>RL)-I%C) IQ\O'<56$DUM*R,[$/Y]
M)4>"2)9D9X&=RTL^?(^N[M$Y_KIQ3C]M\BRXQZPDM!CUHL%!+\!%0E-2+$:]
M==E'94)([]/''W\X_:G?_X(+S%"%TV#V&/S&*$H921<XF-Y<STF&@W@XB.)!
M-/@0'1WNQ/M],3XCQ7\GXF6&2ASP>8OR9%.246]95:N3,'QX>!@\# >4+<+X
MX" *__HZN4V6.$=]4I05*A+<"SC^I*PW3FB"JKKHG>&;&<M4@F'X-)<3(;[U
M%:PO-O6CN#^,!ILR[<D21;C#) J^:> EI^CX^#BLHT]0GHAX4C_1YJL7!-OU
M8S3#-W@>B/<_;L;.T<>A0(0%KB9HAC,^93V\>ESA4:\D^2K#:MN2X;D]3\;8
M4QJQ.L=B=:)#L3H_/V<.7U+>0KCICE8H>YTZZWS-6AO3O+SHJ]=:6E_)5Z^Y
MRGPOQ]]AE7>F>7G14\P(32^*].T+-Z=ZK>)O*\2^@U6:D[V<P-M7O4>I_&!/
MRM42L1P-$IIOLW^FR3K'1756<.4J4CV.BSGE"'%J:"^<@TI>6#R,XNBH+LN?
M;[?,%<,E!]:1"=^@388W%2Y2G*KI1*TO(%)/JR;.:*+-E8DS(65-24H^5ZU'
MB9/!@MZ'*2:A8"L^U+1KROS+O^>47P.<S<J*H:12F3*AS:AGC?$*!2,C%KYY
MH6J9[GA&HTY;2):IA_0J=W4\8WK%B"4J$_^HB=@\74M$N$*,Y^LG2Y(]Z3]G
M-'>M)/66OEO>2:!E""H:Z",I2S$;]0[$91P?.,>,R5W,4W===+:['[ZE@&>\
MVE14?)FAA:&@-2;7P8C!T]!7?(N(QE"I8@18166[IW/F9WXP=^R/5HRQ8QH8
M>.IV(=-Q5S522+7C=Z#V)2D3E/V-$;OD6TJ'W@Z4H7@#!5=S/Z&.JC>22-V'
M[T;WK6_;E;?@K-IK..CJNTGMI;^61CK@%\ .V%Z*7I(,7ZWS&6:&\*ZP7)IF
M&)[,+11:U&V.EJ)^ "_J#5X00:2HKE!NGKM]$$U<$P)58"^53B*;&:30A^"%
M/N?4&,K&_'YT\SM^M"KMP&A2-S!0M?:3Z21V(X54^U?P:H^+A+(5936_6TX3
MG],U)_-X3E/[7MYIA.:$EA%0?;$/T4XN:4DH/7,$WC-W:#-..5LR)]L?53PG
M^Q:LYA,G%JI#NI'KY UG*NF*8_"N.$M33K24;Q-2X,CJ" ].<X,5!]4)[:0Z
MN<":1O5W(+?I7.7''2T0=[1 _)XL8)+Z1@O$SQ: W.-SE3_L:(%A1PL,WY,%
M3%+?:('ALP4@-_ZT\L_YQVMV1Q\*GP&:*)O\NRC@XCL)[2/];A(E/.3.GU9\
M?65[S::,WI/M4SA.]1U0FP4:4. ^\%/;QPR-3,H1\#N!RL[;VQSO<4"'6 \"
M"@)<>3N5O79_E4$I#;\]*"N?TK)"V3]DY6P?^( VU0T@<.U]M/9Q@)%'^0!R
M]U"<L\X81A;E;2'U1(@6@J>NI_06/?612D'('4'QC&PV7=+"_NN-*RR7HQF&
MIV8+A19%FZ.5JI![=K<X63/NQ2B>W0F:AJJNL%R29AB>JBT46E1MCE:J0NZY
MW3$D'KJ_?<QG-#,DM<;D8A@Q>&+ZBF]1TABJGI2!W#>[HEK1EH?</ BY*E8$
M/&';B;3(:TV@1(;<&5-'F(M-LD3% EM^0/=!C".Q#H&G<P<J'8_(>@:E-/P&
MV$6.V8+[] NC#]7RG.8K5-AO?KU([6[(@80G?W=BG>Z''(F4&2 WQ?[D'JYP
MP6O.UX7\5<]\%,Z+D>ODP,"3O@N9%M$=*93<D#M>MS0C":FX5[^B"C."S,LR
M-T =X2T >"JWTF@[NEO&*WTA][FF# M;XB+!]3\HQ!]VV/5\WKA/;@?*A?(!
MX>G>F5:+_KX\R@>0^UQ&_>.R7&/6V0U.N-T3%CAX9[11W,\?EFS*)2_MI9V&
MC26<\ WBS^?;B'@1?];^^#]02P$"% ,4    " !L@9)7)V<A7-41  "9:@
M$0              @ $     968R,# Q-C@V-E\X:RYH=&U02P$"% ,4
M" !L@9)7LGX27+D0   R0P  %0              @ $$$@  968R,# Q-C@V
M-E]E>#DY+3$N:'1M4$L! A0#%     @ ;(&25_TG@T9% P  0P\  !$
M         ( !\"(  &EO;G,M,C R,S$R,3@N>'-D4$L! A0#%     @ ;(&2
M5XT$STR "   =5@  !4              ( !9"8  &EO;G,M,C R,S$R,3A?
M;&%B+GAM;%!+ 0(4 Q0    ( &R!DE>)-*48W04  /@^   5
M  "  1<O  !I;VYS+3(P,C,Q,C$X7W!R92YX;6Q02P4&      4 !0!' 0
&)S4

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
